Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

55%

Threshold

Crossed downwards

Timeline

Published

18.03.2022

Transaction

14.03.2022

Voting rights breakdown

Voting rights acquired29.49%
Voting rights sold55%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAM3H00031

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

Acquisition and disposal of shares on March 14, 2022; also regarding certain sale positions.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open